RecruitingNCT04898335

Tendyne European Experience Registry

TENDyne European expeRience Registry

Sponsor

LMU Klinikum

Enrollment

400 participants

Start Date

Apr 15, 2021

Study Type

OBSERVATIONAL

Conditions

Mitral Regurgitation

Summary

TENDER is a multicenter, single-device, retrospective and prospective, observational study to assess safety and efficacy of the Tendyne Mitral Valve System in a real-world population.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Tendyne Mitral Valve System for people with mitral regurgitation. The study is currently recruiting participants at 30 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETendyne Mitral Valve System

Tendyne Mitral Valve System for mitral valve disease in a commercial setting

Locations(30)

Universitaetsklinikum Linz

Linz, Austria

Universitaetsklinikum Wien

Vienna, Austria

UZ Leuven

Leuven, Belgium

CHU de Bordeaux

Bordeaux, France

CHU de Lille

Lille, France

CHU Rennes

Rennes, France

Clinique Pasteur

Toulouse, France

Herz- und Diabeteszentrum NRW

Bad Oeynhausen, Germany

Deutsches Herzzentrum Berlin

Berlin, Germany

Universitaetsklinikum Bonn

Bonn, Germany

Universitaetsklinikum Koeln

Cologne, Germany

Universitätsklinikum Frankfurt

Frankfurt, Germany

UKE Hamburg

Hamburg, Germany

Herzentrum Leipzig

Leipzig, Germany

Universitätsmedizin Mainz

Mainz, Germany

DHZ München

Münich, Germany

Universitaetsklinikum Regensburg

Regensburg, Germany

Robert-Bosch-Krankenhaus Stuttgart

Stuttgart, Germany

Universitaetsklinikum Tuebingen

Tübingen, Germany

ICH - Istituto Clinico Humanitas

Milan, Italy

University Hospital of Pisa

Pisa, Italy

University hospital Oslo

Oslo, Norway

Puerto de Hierro Madrid

Madrid, Spain

University hospital Madrid

Madrid, Spain

Hospital Clinico Valladolid

Valladolid, Spain

University Hospital of Vigo

Vigo, Spain

Karolinska University Stockholm

Stockholm, Sweden

Universitaetsspital Basel

Basel, Switzerland

Inselspital Bern

Bern, Switzerland

Royal Brompton London

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04898335

Related Trials

ATLAS (AltaValve) Pivotal Trial

NCT0646574529 locations

The REValve Clinical Trial an Evaluation Of the ReValve Palmetto Valve for the Replacement of the Native Mitral VaLVE

NCT074509113 locations

Capstan Medical TMVR Study: FIH

NCT066001913 locations

Cephea Early Feasibility Study

NCT0506100422 locations

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

NCT0549699837 locations